“Dream team” of researchers tackles leading cause of vision loss
July 27, 2022 - Dr. Catherine Tsilfidis has assembled a world-class team to bring discoveries with game-changing potential to patients with retinal disease |
$2.4 M grant to help researchers develop gene and cell therapies for a leading cause of blindness
September 15, 2021 - A team led by Dr. Catherine Tsilfidis has received $2.4 M from the Ontario Research Fund to develop treatments for retinal diseases, a leading cause of blindness. |
Ottawa Hospital Research Institute and Faculty of Medicine support three translational research projects through Blueprint Excelerator
March 10, 2021 - The Ottawa Hospital Research Institute (OHRI) and the Faculty of Medicine are providing up to $150,000 in in-kind support to help translate three laboratory research projects into clinical applications. The three projects will receive support ... |
$145,000 grant helps researchers investigate how newts regrow limbs and organs
July 27, 2016 - Dr. Catherine Tsilfidis received a $145K grant from the Natural Sciences and Engineering Research Council of Canada to study the cellular process that lets newts regrow limbs and organs, and examine how it differs from mammalian cells. When a new |
$670,000 grant supports research on two-pronged approach for degenerative retinal disease
February 24, 2016 - Dr. Catherine Tsilfidis has received a $670,000 grant from the Canadian Institutes of Health Research (CIHR) to test an experimental combination therapy for preventing the degeneration of the retina, the light-sensitive back of the eye where imag |
